SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

With no major difference for the quarter endedJune 2022 , the total revenue stood at Rs. 7294.60  millions.Net profit stood at Rs. 1156.30  millions  compared to Rs. 1066.00 millions in the corresponding previous quarter,high by 8.47%.OP of the company witnessed a marginal growth to 1757.20 millions from 1634.70 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 7294.60 7018.40 3.94 7294.60 7018.40 3.94 32175.10 29204.70 10.17
Other Income 277.90 317.30 -12.42 277.90 317.30 -12.42 762.20 1101.90 -30.83
PBIDT 1757.20 1634.70 7.49 1757.20 1634.70 7.49 8320.50 7079.60 17.53
Interest 6.80 7.90 -13.92 6.80 7.90 -13.92 19.90 35.30 -43.63
PBDT 1750.40 1626.80 7.60 1750.40 1626.80 7.60 8416.40 5318.30 58.25
Depreciation 158.20 175.40 -9.81 158.20 175.40 -9.81 681.90 786.00 -13.24
PBT 1592.20 1451.40 9.70 1592.20 1451.40 9.70 7734.50 4532.30 70.65
TAX 435.90 385.40 13.10 435.90 385.40 13.10 3968.70 1665.40 138.30
Deferred Tax -34.70 -34.80 -0.29 -34.70 -34.80 -0.29 -105.00 78.70 -233.42
PAT 1156.30 1066.00 8.47 1156.30 1066.00 8.47 3765.80 2866.90 31.35
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 24.09 23.29 3.42 24.09 23.29 3.42 25.86 24.24 6.68

Glaxosmithkline Phar Share Price

2451.80 32.70 (1.35%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×